News Releases

News Releases

Jul 07, 2021
PRINCETON, N.J. --(BUSINESS WIRE)--Jul. 7, 2021-- UroGen Pharma Ltd (Nasdaq:URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced that it will present at the Ladenburg Thalmann Healthcare
May 25, 2021
PRINCETON, N.J. --(BUSINESS WIRE)--May 25, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced that it will present at the following virtual conferences in